Position statement: <scp>LEPROSY</scp>: Diagnosis, treatment and follow‐up

Journal of the European Academy of Dermatology and Venereology - Tập 33 Số 7 - Trang 1205-1213 - 2019
W. Alemu Belachew1, Bernard Naafs1,2,3,4
1Department of Dermatovenereology, Ayder Referral Hospital Mekelle University, Mekelle, Tigray, Ethiopia
2Foundation Global Dermatology, Munnekeburen, The Netherlands
3Instituto Lauro de Souza Lima (ILSL), Bauru, SP, Brazil
4Regional Dermatology Training Centre (RDTC), Moshi, Tanzania

Tóm tắt

AbstractBackgroundLeprosy or Hansen's disease is a chronic infection caused by Mycobacterium leprae (M. leprae) or Mycobacterium lepromatosis (M. lepromatosis). In Europe, most of the leprosy cases are imported. However, occasionally a case is diagnosed in one of the old endemic foci. Leprosy is often not suspected because it is no longer emphasized in the medical curricula. Attention shifted from leprosy to tuberculosis and human immunodeficiency virus infections in the late 20th century, whereby the WHO leprosy programme was toned down in the conviction that leprosy was all but eliminated. The result of unawareness is a harmful doctor's delay.Material and methodsThis paper focusses on clinical diagnosis, complications and treatment based on literature and experience.ResultsIt mentions the value of laboratory tests in classification, follow‐up and detection of relapses. It discusses the etiopathology.ConclusionThis is a position statement.

Từ khóa


Tài liệu tham khảo

10.4269/ajtmh.12-0214

Kumar B, 2007, Leprosy, Lepr Rev, 78, 5

Lockwood DN, 2005, Leprosy: too complex a disease for a simple elimination paradigm, Bull World Health Organ, 83, 230

10.1046/j.1365-3156.2000.00579.x

10.1111/j.1468-3083.2008.03006.x

10.1007/s00401-015-1404-5

Naafs B, 2000, Current views on reactions in leprosy, Indian J Lepr, 72, 97

WHO. URLhttp://www.who.int/lep/diagnosis/en/. (last accessed 27‐03‐2019).

10.1016/j.clindermatol.2015.10.014

Antia NH, 1970, Nerves in the arm in leprosy. 1. Clinical, electrodiagnostic and operative aspects, Int J Lepr Other Mycobact Dis, 38, 12

1987, WHO guidelines for skin smears, Int J Lepr Other Mycobact Dis, 52, 421

BarretoJA. URLhttp://leprosymailinglist.blogspot.com/2013/12/lml-taking-and-processing-of-slit-skin.html(last accessed 27‐03‐2019).

10.5935/0305-7518.19920004

Hirawati, 2006, Detection of M. leprae by reverse transcription‐ PCR in biopsy specimens from leprosy cases: a preliminary study, J Commun Dis, 38, 280

10.1016/j.clindermatol.2015.10.013

10.4103/ijmr.IJMR_109_18

Weddell GM, 1975, Leprosy–histopathologic aspects of nerve involvement, Contemp Neurol Ser, 12, 17

Theuvenet WJ, 1996, Cytological needle aspiration for the diagnosis of pure neural leprosy, Indian J Lepr, 68, 109

10.4103/ijd.IJD_115_17

10.1016/S0140-6736(74)93043-8

10.1016/j.cell.2012.12.014

Ridley DS, 1966, Classification of leprosy according to immunity. A five‐group system, Int J Lepr Other Mycobact Dis, 34, 255

10.1007/978-88-470-2376-5_16

World Health Organization (WHO), 1995, Guide to Eliminate Leprosy as a Public Health Problem

HaggeDA ThapaP ShresthaIRet al.Is counting the lesions enough: the significance of slit skin smears and biopsy histopathology in the clinical diagnosis treatment and classifications of leprosy patients. Paper at the 18th world leprosy congress; 2013

Mouat FJ, 1854, Notes on native remedies. No. 1. The Chaulmoogra, Indian Ann Med Sci, 1, 646

10.2307/4584691

Pattyn SR, 1977, The chemotherapy of leprosy from a microbiological standpoint, Lepr India, 49, 526

WHO, 1982, Chemotherapy of leprosy for control programmes, World Health Organ Tech Rep Series, 675, 1

WHO Guidelines for the diagnosis treatment and prevention of leprosy.2018:15–27.http://www.searo.who.int/entity/global_leprosy_programme/documents/9789290226383/en/

10.47276/lr.83.3.221

SalgadoC.Manifest against the implementation of MDT‐U. Leprosy Mailing List June 12 2018

RaoPN.Manifest against the implementation of MDT‐U Leprosy Mailing List. June 25 2018

Wang N, 2017, A review on dapsone hypersensitivity syndrome among Chinese patients with an emphasis on preventing adverse drug reactions with genetic testing, Am J Trop Med Hyg, 96, 1014

10.1111/j.1365-3156.2011.02873.x

Bjune G, 1976, Lymphocyte transformation test in leprosy; correlation of the response with inflammation of the lesions, Clin Exp Immunol, 25, 85

10.1016/j.clindermatol.2015.10.006

Naafs B, 1994, Reaction: New knowledge, Trop Geogr Med, 46, 80

10.1371/journal.pntd.0006001

10.4269/ajtmh.15-0673

Naafs B, 1977, Sensory testing: a sensitive method in the follow‐up of nerve involvement, Int J Lepr Other Mycobact Dis, 45, 364

Brandsma W, 1981, Basic nerve function assessment in leprosy patients, Lepr Rev, 52, 161

Naafs B, 2003, Treatment duration of reversal reaction: a reappraisal. Back to the past, Lepr Rev, 74, 328, 10.47276/lr.74.4.328

10.1016/S0140-6736(76)91684-6

De Souza ArauyoHC.Inst Oswaldo Cruz Rio de Janeiro Thesis 1929.

WHO.https://www.who.int/lep/research/WHOenlguide.pdf

10.1007/978-3-319-39424-4_6

10.1371/journal.pntd.0002690

Schreuder PAM, 2003, Chronic recurrent ENL, steroid dependant: long‐term treatment with high dose of clofazimine, Lepr Rev, 74, 386, 10.47276/lr.74.4.386

10.1080/08923970802135161

10.1212/01.WNL.0000037480.59194.85

10.1489/1544-581X(2004)72<480:MIRE>2.0.CO;2

Hossain D, 2013, Using methotrexate to treat patients with ENL unresponsive to steroids and clofazimine: a report on 9 patients, Lepr Rev, 84, 105

Droogenbroeck JBA, 1977, Etude comparative d'une série de nerfs lépreux décomprimés chirurgicalement par rapport aux nerfs contralatéraux non‐opérés, Méd Trop, 37, 771

Van Veen NH, 2012, Decompressive surgery for treating nerve damage in leprosy, Cochrane Database Syst Rev, 12, CD006983

10.1097/DAD.0000000000000766

10.1111/j.1699-0463.1991.tb05127.x

10.1186/1471-2334-13-456

10.1186/s12879-018-3402-4

10.1128/AAC.00722-09